WASHINGTON, DC — A key women's health expert at the FDA, Dr. Susan Wood, assistant commissioner for women's health and director of the Office of Women's Health at the Food and Drug Administration (FDA), resigned today in protest of the FDA's handling of the application to make Plan B emergency contraception (EC) available over the counter.

Jan. 30, 2014 • National

Comprehensive Scientific Data Submitted to the FDA Two Years Ago Shows Emergency Contraception Should Be Available Over the Counter

Jan. 30, 2014 • National

Planned Parenthood Calls on FDA to Stop Playing Politics and to Focus on Science and Public Health

Jan. 30, 2014 • National

Planned Parenthood Federation of America (PPFA) applauds the decision by the U.S. Food and Drug Administration (FDA) to approve the sale and use of ulipristal acetate (UPA), a new form of emergency contraception (EC).

Jan. 30, 2014 • National

Public Health Ignored; Ideology Trumps Science — Emergency Contraception Is Safe, Effective and Meets All FDA Criteria For Over- the-Counter Status

Jan. 30, 2014 • National

Agency to Initiate Rulemaking Proceeding on 'Dual Label' Concept

Jan. 30, 2014 • National

Planned Parenthood Demands Return to Science and Public Health Focus, Not Politics and Ideology

Jan. 30, 2014 • National

FDA Approves Long-Term, Reversible Birth Control Method; Planned Parenthood Clinicians Will Be Trained This October to Provide Implanon

Jan. 30, 2014 • National

Washington, DC — Planned Parenthood Federation of America (PPFA) applauds the vote today by the U.S. Food and Drug Administration’s (FDA) Advisory Committee for Reproductive Health Drugs that ulipristal acetate (UPA), a new form of emergency contraception (EC), is safe and effective.

Jan. 30, 2014 • National